Bedsore is a curse in disguise: capturing the zeitgeist


  • Anand Yadav Department of General Surgery, LN Medical College, Bhopal, Madhya Pradesh
  • Rituja Kaushal Department of Community Medicine, LN Medical College, Bhopal, Madhya Pradesh



Bedsore, Bhopal, Pressure Injuries, Prevention, Rates


Background: Development of a bedsore is always avoidable still its worldwide prevalence fluctuates between 0%-56%. Bedsores are maximally observed in patients who are on long term care, in intensive care, immuno-compromised or on home care.

Methods: In a tertiary care center-JK hospital, Bhopal, a longitudinal observational study was done for a duration of 3 years, on all registered in-patients, to understand the trend of bedsore rates on monthly basis.

Results: In our study, even though, on yearly basis, average of rates is showing a declining trend in favorable manner yet higher statistical analysis (ANOVA test p value = 0.054) has decrypted the non-significant results.

Conclusions: Timely and appropriate prophylactic interventions are needed to overcome the increased bedsore rates. Checklist based surveillance and monitoring should be a pressing priority. Cochrane reviews are also suggestive of incorporation of organizational changes, risk assessment tools, wound care teams and education to reduce the incidence of pressure ulcers.

Author Biographies

Anand Yadav, Department of General Surgery, LN Medical College, Bhopal, Madhya Pradesh

Assistant Professor, General Surgery
LNMC & RC, Bhopal

Rituja Kaushal, Department of Community Medicine, LN Medical College, Bhopal, Madhya Pradesh

Community Medicine, Associate Professor


Bhattacharya S, Mishra RK. Pressure ulcers: current understanding and newer modalities of treatment. Indian J Plastic Surg. 2015;48(1):4-16.

Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: Extent of the problem and provision of care. Br Med J. 1985;290:1855-6.

Krouskop TA, Reddy NP, Spencer WA, Secor JW. Mechanisms of decubitus ulcer formation: an hypothesis. Med Hypotheses. 1978;4:37-9.

Reddy NP, Patel K. A mathematical model of flow through the terminal lymphatics. Med Eng Phys. 1995;17:134-40.

Pressure ulcer advisory panel announces a change in terminology from pressure ulcer to pressure injury. Available at: in-terminology-from-pressure-ulcer-to-pressure-injury-and-updates-the-stages-of-pressure-injury/. Accessed on 12 December 2019.

Agrawal K, Chauhan N. Pressure ulcers: back to the basics. Indian J Plast Surg. 2012;45(2):244-54.

Mosher BA, Cuddigan J, Thomas DR, Boudreau DM. Outcomes of 4 methods of debridement using a decision analysis methodology. Adv Wound Care. 1999;12:81-8.

Ramundo J, Gray M. Enzymatic wound debridement. J Wound Ostomy Continence Nurs. 2008;35:273-80.

Mumcuoglu KY, Lipo M, Uspensky I, Miller J, Galun R. Maggot therapy for gangrene and osteomyelitis. Harefuah. 1997;132:323-5.

Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen. 2002;10:208-14.

Moore ZE, Cowman S. Wound cleansing for pressure ulcers. Cochrane Database Syst Rev. 2005;3:CD004983.

Ramundo J, Gray M. Is ultrasonic mist therapy effective for debriding chronic wounds? J Wound Ostomy Continence Nurs. 2008;35:579-83.

Kavros SJ, Liedl DA, Boon AJ, Miller JL, Hobbs JA, Andrews KL. Expedited wound healing with noncontact, low-frequency ultrasound therapy in chronic wounds: a retrospective analysis. Adv Skin Wound Care. 2008;21:416-23.

Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH, Squibb KS. Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns. 2002;28:719-30.

Kaur S, Singh A, Dhillon MS, Tewari MK, Sekhon PK. Incidence of bedsore among the admitted patients in a tertiary care hospital. J Postgrad Med Edu Res. 2015;49(1):26-31.

Singh M, Dhanda K. Prevalence and clinical evaluation of pressure ulcers using Braden scale from orthopedics wards of a tertiary care teaching hospital. IAIM. 2015;2(3):21-7.

Payne WG, Ochs DE, Meltzer DD, Hill DP, Mannari RJ, Robson LE. Long-term outcome study of growth factor-treated pressure ulcers. Am J Surg. 2001;181:81-6.

Marston WA. Dermagraft, a bioengineered human

dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer. Expert Rev Med Devices. 2004;1:21-31.

Sarasúa GJ, López PS, Viejo AM, Basterrechea PM, Rodríguez PA, Gutiérrez FA, et al. Treatment of pressure ulcers with autologous bone marrow nuclear cells in patients with spinal cord injury. J Spinal Cord Med. 2011;34:301-7.

Kamata Y, Takahashi Y, Iwamoto M, Matsui K, Murakami Y, Muroi K, et al. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatol. 2007;46:882-4.

Robson MC, Hill DP, Smith PD, Wang X, Siegler MK, Ko F, et al. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. Ann Surg. 2000;231:600-11.

Biji SM. Burden and outcomes of pressure ulcers in cancer patients receiving the Kerala model of home based palliative care in India. Indian J Palliative Care. 2015;21(2):152-7.

Bicer EK. Pressure ulcer prevalence, incidence, risk, clinical features and outcomes among patients in a Turkish Hospital: a cross sectional, retrospective study. Wound Management Prevention. 2019;65(2):20-8.






Original Research Articles